首页> 外文期刊>Virology Journal >The dual role of tetraspanin CD63 in HIV-1 replication
【24h】

The dual role of tetraspanin CD63 in HIV-1 replication

机译:四跨膜蛋白CD63在HIV-1复制中的双重作用

获取原文
获取外文期刊封面目录资料

摘要

Background Previously, we showed that the tetraspanin membrane protein CD63 mediates both early and post-integration stages of the HIV-1 replication cycle. The temporal roles of CD63 were discerned using monoclonal antibodies and small interfering RNAs (siRNAs) to block CD63 function, and determining which of the sequential steps in HIV-1 replication were disrupted. Inhibition was shown to occur during early infection, suggestive of involvement in virus entry or reverse transcription. In addition, we have shown that treatment with CD63 siRNA post-infection, significantly inhibited virus production in supernatant, suggesting an important role for CD63 in macrophages during HIV-1 replication events occurring after proviral integration, and possibly during egress. Results In this study we used CD63 siRNA to investigate the infectivity of pseudotyped viruses (carrying an NL4-3 Env-negative luciferase backbone) in primary human macrophages. We demonstrated that lab adapted R5- and R5X4-tropic HIV-1 strains are significantly inhibited by CD63 silencing. However, the infectivity of MLV or VSV-pseudotyped strains, which enter though receptor-mediated endocytosis, is unaffected by silencing CD63. These results indicate that CD63 may support Env-mediated entry or fusion events facilitated though CD4 and CCR5. Also, antibody and siRNA-based CD63 inhibition studies indicate a potential role for CD63 following proviral integration. Further, we show that CD63 expression is key for efficient replication in primary CD4+ T cells, complementing our prior studies with primary human macrophages and immortalized cell lines. Conclusions Collectively, these findings indicate that CD63 may support Env-mediated fusion as well as a late (post-integration) step in the HIV-1 replication cycle.
机译:背景技术以前,我们表明四跨膜蛋白CD63介导了HIV-1复制周期的早期和整合后阶段。使用单克隆抗体和小分子干扰RNA(siRNA)来阻断CD63的功能,从而确定CD63的暂时性作用,并确定破坏了HIV-1复制中的哪些顺序步骤。已显示抑制作用发生在早期感染期间,提示参与病毒进入或逆转录。此外,我们已经表明,感染后用CD63 siRNA进行的处理可显着抑制上清液中的病毒产生,这表明CD63在巨噬细胞中在前病毒整合后可能发生的HIV-1复制事件中可能起重要作用,并且可能在流出过程中发挥重要作用。结果在这项研究中,我们使用CD63 siRNA来研究假型病毒(携带NL4-3 Env阴性荧光素酶主链)在原代人巨噬细胞中的感染力。我们证明了CD63沉默可显着抑制实验室适应性的R5-和R5X4-tropic HIV-1菌株。但是,通过受体介导的内吞作用进入的MLV或VSV假型菌株的感染性不受CD63沉默的影响。这些结果表明CD63可能支持通过CD4和CCR5促进的Env介导的进入或融合事件。同样,基于抗体和基于siRNA的CD63抑制研究表明原病毒整合后CD63的潜在作用。此外,我们证明了CD63表达是在原代CD4 + T细胞中有效复制的关键,这补充了我们先前对原代人类巨噬细胞和永生化细胞系的研究。结论总体而言,这些发现表明CD63可能支持Env介导的融合以及HIV-1复制周期的后期(整合后)步骤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号